Skip to main content
Erschienen in: Acta Neurochirurgica 3/2013

01.03.2013 | Clinical Article - Brain Tumors

Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases

verfasst von: Jan Frederick Cornelius, Philipp Jörg Slotty, Hans Jakob Steiger, Daniel Hänggi, Marc Polivka, Bernard George

Erschienen in: Acta Neurochirurgica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

About 90 % of meningiomas are benign (WHO grade I), atypical and anaplastic variants exist (WHO grade II/III, 10 %). Tumour grade has important implications for management. Non-invasive diagnosis of tumour grade is still not feasible. The purpose of this survey was to analyse epidemiological risk factors such as sex, age and location for a higher grade (WHO grade II/III) meningioma in a large surgical series.

Methods

A retrospective study comprising 1,663 patients operated on for an intracranial meningioma in a single tertiary-care centre. The population was analysed for correlations including WHO grade, histological subtype, tumour localisation, patient age and gender. Additionally correlations between Ki67 index/WHO grade and localisation were analysed.

Results

A binary logistic regression analysis revealed non-skull base localisation (OR 1.779 [CI 1.069–2.960, p = 0.0027]) and age ≥65 years (OR 1.549 [CI 1.214–2.624, p = 0.012]) as significant risk factors for a higher WHO grade. Male gender showed a trend for a higher risk in χ2 analysis. An analysis of the Ki67 index revealed an increased index for non-skull base localisation compared with skull base (p < 0.001). Correlation analysis of Ki67 distribution in WHO grade I meningiomas revealed higher Ki67 indices for non skull base localisation (p = 0.0024).

Conclusions

Non-skull base localisation and age ≥65 years are independent risk factors for higher grade meningiomas. In other terms, the malignant potential of skull base meningiomas is low. This information is important when advising a patient about individual treatment options (observation, surgery or radio-surgery) and prognosis.
Literatur
1.
Zurück zum Zitat Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60, discussion 60PubMedCrossRef Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60, discussion 60PubMedCrossRef
2.
Zurück zum Zitat Buccoliero AM, Castiglione F, Degl’Innocenti DR, Gheri CF, Garbini F, Taddei A, Ammannati F, Mennonna P, Taddei GL (2007) NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study. Neuropathology 27:36–42PubMedCrossRef Buccoliero AM, Castiglione F, Degl’Innocenti DR, Gheri CF, Garbini F, Taddei A, Ammannati F, Mennonna P, Taddei GL (2007) NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study. Neuropathology 27:36–42PubMedCrossRef
3.
Zurück zum Zitat Cea-Soriano L, Blenk T, Wallander MA, Rodriguez LA (2011) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36:198-205 Cea-Soriano L, Blenk T, Wallander MA, Rodriguez LA (2011) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36:198-205
4.
Zurück zum Zitat Chamberlain MC, Barnholtz-Sloan JS (2011) Medical treatment of recurrent meningiomas. Expert Rev Neurother 11:1425–1432PubMedCrossRef Chamberlain MC, Barnholtz-Sloan JS (2011) Medical treatment of recurrent meningiomas. Expert Rev Neurother 11:1425–1432PubMedCrossRef
5.
Zurück zum Zitat Chamberlain MC, Glantz MJ (2008) Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 113:2146–2151PubMedCrossRef Chamberlain MC, Glantz MJ (2008) Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 113:2146–2151PubMedCrossRef
6.
Zurück zum Zitat Cornelius JF, Langen KJ, Stoffels G, Hanggi D, Sabel M, Steiger HJ (2012) PET imaging of meningioma in clinical practice: review of literature and future directions. Neurosurgery 70(4):1033–1041, discussion 1042PubMedCrossRef Cornelius JF, Langen KJ, Stoffels G, Hanggi D, Sabel M, Steiger HJ (2012) PET imaging of meningioma in clinical practice: review of literature and future directions. Neurosurgery 70(4):1033–1041, discussion 1042PubMedCrossRef
7.
Zurück zum Zitat Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375PubMedCrossRef Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375PubMedCrossRef
8.
Zurück zum Zitat Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H (2006) Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 182:641–646PubMedCrossRef Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H (2006) Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 182:641–646PubMedCrossRef
9.
Zurück zum Zitat Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233–242PubMedCrossRef Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233–242PubMedCrossRef
10.
Zurück zum Zitat Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333–2344PubMedCrossRef Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333–2344PubMedCrossRef
11.
Zurück zum Zitat Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272–1278PubMedCrossRef Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272–1278PubMedCrossRef
12.
Zurück zum Zitat Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–296, discussion 296–297PubMedCrossRef Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–296, discussion 296–297PubMedCrossRef
13.
Zurück zum Zitat Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, Lenhof HP (2006) A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors. BMC Bioinforma 7:539CrossRef Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, Lenhof HP (2006) A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors. BMC Bioinforma 7:539CrossRef
14.
Zurück zum Zitat Kim DG, Kim Ch H, Chung HT, Paek SH, Jeong SS, Han DH, Jung HW (2005) Gamma knife surgery of superficially located meningioma. J Neurosurg 102(Suppl):255–258PubMedCrossRef Kim DG, Kim Ch H, Chung HT, Paek SH, Jeong SS, Han DH, Jung HW (2005) Gamma knife surgery of superficially located meningioma. J Neurosurg 102(Suppl):255–258PubMedCrossRef
15.
Zurück zum Zitat Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887PubMedCrossRef Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887PubMedCrossRef
16.
Zurück zum Zitat Kollova A, Liscak R, Novotny J Jr, Vladyka V, Simonova G, Janouskova L (2007) Gamma Knife surgery for benign meningioma. J Neurosurg 107:325–336PubMedCrossRef Kollova A, Liscak R, Novotny J Jr, Vladyka V, Simonova G, Janouskova L (2007) Gamma Knife surgery for benign meningioma. J Neurosurg 107:325–336PubMedCrossRef
17.
Zurück zum Zitat Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21:2149–2156PubMedCrossRef Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21:2149–2156PubMedCrossRef
18.
Zurück zum Zitat Lohmann CM, Brat DJ (2000) A conceptual shift in the grading of meningiomas. Adv Anat Pathol 7:153–157PubMedCrossRef Lohmann CM, Brat DJ (2000) A conceptual shift in the grading of meningiomas. Adv Anat Pathol 7:153–157PubMedCrossRef
19.
Zurück zum Zitat Ludwig N, Keller A, Heisel S, Leidinger P, Rheinheimer S, Andres C, Stephan B, Steudel WI, Donauer E, Graf N, Burgeth B, Weickert J, Lenhof HP, Meese E (2011) Novel immunogenic antigens increase classification accuracy in meningioma to 93.84 %. Int J Cancer 128:1493–1501PubMedCrossRef Ludwig N, Keller A, Heisel S, Leidinger P, Rheinheimer S, Andres C, Stephan B, Steudel WI, Donauer E, Graf N, Burgeth B, Weickert J, Lenhof HP, Meese E (2011) Novel immunogenic antigens increase classification accuracy in meningioma to 93.84 %. Int J Cancer 128:1493–1501PubMedCrossRef
20.
Zurück zum Zitat McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY (2010) A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg 112:925–933PubMedCrossRef McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY (2010) A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg 112:925–933PubMedCrossRef
21.
Zurück zum Zitat Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schutze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sanchez MJ, Rodriguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562–2569PubMedCrossRef Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schutze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sanchez MJ, Rodriguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562–2569PubMedCrossRef
22.
Zurück zum Zitat Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2007) Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 68:858–863PubMedCrossRef Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2007) Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 68:858–863PubMedCrossRef
23.
Zurück zum Zitat Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550, discussion 538–550PubMedCrossRef Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550, discussion 538–550PubMedCrossRef
24.
Zurück zum Zitat Moradi A, Semnani V, Djam H, Tajodini A, Zali AR, Ghaemi K, Nikzad N, Madani-Civi M (2008) Pathodiagnostic parameters for meningioma grading. J Clin Neurosci 15:1370–1375PubMedCrossRef Moradi A, Semnani V, Djam H, Tajodini A, Zali AR, Ghaemi K, Nikzad N, Madani-Civi M (2008) Pathodiagnostic parameters for meningioma grading. J Clin Neurosci 15:1370–1375PubMedCrossRef
25.
Zurück zum Zitat Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J (1999) Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455–462PubMedCrossRef Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J (1999) Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455–462PubMedCrossRef
26.
Zurück zum Zitat Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054PubMedCrossRef Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054PubMedCrossRef
27.
Zurück zum Zitat Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH (2007) World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:1194–1198, discussion 1198PubMedCrossRef Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH (2007) World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:1194–1198, discussion 1198PubMedCrossRef
28.
Zurück zum Zitat Sioka C, Kyritsis AP (2009) Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. J Neurooncol 92:1–6PubMedCrossRef Sioka C, Kyritsis AP (2009) Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. J Neurooncol 92:1–6PubMedCrossRef
29.
Zurück zum Zitat van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC (2007) Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84:271–278PubMedCrossRef van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC (2007) Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84:271–278PubMedCrossRef
30.
Zurück zum Zitat van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC (2006) Lack of genetic and epigenetic changes in meningiomas without NF2 loss. J Pathol 208:564–573PubMedCrossRef van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC (2006) Lack of genetic and epigenetic changes in meningiomas without NF2 loss. J Pathol 208:564–573PubMedCrossRef
31.
32.
Zurück zum Zitat Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314PubMedCrossRef Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314PubMedCrossRef
Metadaten
Titel
Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases
verfasst von
Jan Frederick Cornelius
Philipp Jörg Slotty
Hans Jakob Steiger
Daniel Hänggi
Marc Polivka
Bernard George
Publikationsdatum
01.03.2013
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 3/2013
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-012-1611-y

Weitere Artikel der Ausgabe 3/2013

Acta Neurochirurgica 3/2013 Zur Ausgabe

Editorial - Neurosurgery Training

Neurosurgical training under European law

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.